Stock Information
Autolus Therapeutics PLC (AUTL)
Ticker Symbol: AUTL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $396.55 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.0857
Revenue (TTM): $0.35 M
Dividend Yield: N/A%
ROE: -128.59%
Latest News
-
Autolus Therapeutics plc 2026 Q2 - Results - Earnings Call Presentation
Tue, Aug 11, 2026 3:02 PM
-
Autolus Therapeutics plc (AUTL) Q2 2026 Earnings Call Transcript
Tue, Aug 11, 2026 12:47 PM
-
Autolus Therapeutics Affirms FY2026 Sales Guidance of $140.000M-$150.000M vs $136.669M Est
Tue, Aug 11, 2026 7:01 AM
-
Autolus Therapeutics Q2 EPS $(0.15) Beats $(0.23) Estimate, Sales $45.689M Beat $34.016M Estimate
Tue, Aug 11, 2026 7:00 AM
Key Financials
Financial data not available
